摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,3-二甲氧基-菲-9-羧酸 | 35675-92-4

中文名称
2,3-二甲氧基-菲-9-羧酸
中文别名
——
英文名称
2,3-dimethoxy-phenanthrene-9-carboxylic acid
英文别名
2,3-Dimethoxy-phenanthren-9-carbonsaeure;2,3-Dimethoxyphenanthrene-9-carboxylic acid
2,3-二甲氧基-菲-9-羧酸化学式
CAS
35675-92-4
化学式
C17H14O4
mdl
——
分子量
282.296
InChiKey
ZJDIJOCYDSBPBK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.9
  • 重原子数:
    21
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.12
  • 拓扑面积:
    55.8
  • 氢给体数:
    1
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Synthesis and antioxidant activity of hydroxylated phenanthrenes as cis-restricted resveratrol analogues
    作者:De-Jun Ding、Xiao-Yan Cao、Fang Dai、Xiu-Zhuang Li、Guo-Yun Liu、Dong Lin、Xing Fu、Xiao-Ling Jin、Bo Zhou
    DOI:10.1016/j.foodchem.2012.05.074
    日期:2012.12
    Five hydroxylated phenanthrenes as "cis-configuration-fixed" resveratrol analogues differing in the number and position of the hydroxyl groups were designed and synthesized. Their antioxidant activity was studied by ferric reducing antioxidant power, 2,2-diphenyl-1-picrylhydrazyl free radical-scavenging, and DNA strand breakage-inhibiting assays, corresponding to their electron-donating, hydrogen-transfer and DNA-protecting abilities, respectively. In the above assays, their activity depends significantly on the number and position of the hydroxyl groups, and most of them are more effective than resveratrol. Noticeably, compound 9b (2,4,6-trihydroxyl phenanthrene) with the same hydroxyl group substitutions as resveratrol, is superior to the reference compound, highlighting the importance of extension of the conjugation over multiple aromatic-rings. Similar activity sequences were obtained in different experimental models, but the appreciable differences could contribute detailed insights into antioxidant mechanisms. Based on these results, the hydroxylated phenanthrenes may be considered as a novel type of resveratrol-directed antioxidants. (C) 2012 Elsevier Ltd. All rights reserved.
  • Pschorr; Buckow, Chemische Berichte, 1900, vol. 33, p. 1830
    作者:Pschorr、Buckow
    DOI:——
    日期:——
  • Cook et al., Journal of the Chemical Society, 1954, p. 4234,4237
    作者:Cook et al.
    DOI:——
    日期:——
  • [EN] NOVEL PHARMACEUTICAL COMPOSITION COMPRISING ALKALOID AND PROCESS THEREOF<br/>[FR] COMPOSITION PHARMACEUTIQUE RENFERMANT UN OU PLUSIEURS ALCALOIDES ET PROCEDE
    申请人:PANACEA BIOTEC LTD
    公开号:WO2007046113A2
    公开(公告)日:2007-04-26
    [EN] Novel anti-inflammatory, antiallergic and/or antiasthmatic pharmaceutical compositions comprising at least one alkaloid component(s) derived from natural, semi-synthetic or synthetic source as active agent, either alone or in combination with other active agent(s), optionally with other pharmaceutically acceptable excipients is provided. Also provided are process of preparation of such compositions and method of using such compositions. The novel composition is preferably in the form of a dry powder inhaler or metered dose inhaler and is preferably intended to be administered by pulmonary, nasal or oral route, most preferably by inhalation, and is useful either prophylactically or therapeutically particularly in the prevention or treatment of inflammatory, allergic, and/or respiratory disorders such as asthma and/or chronic obstructive pulmonary disease(s), or any other associated disorders.
    [FR] Compositions pharmaceutiques antiinflammatoires, antiallergiques et/ou antiasthmatiques comprenant au moins un ou plusieurs composants alcaloïdes dérivés d'une source naturelle, semi-synthétique ou synthétique, comme principe actif, soit isolément soit en combinaison avec un ou plusieurs autres principes actifs, éventuellement avec d'autres excipients pharmaceutiquement acceptables. On décrit aussi des procédés d'élaboration et d'utilisation correspondants. De préférence, ce type de composition se présente sous la forme d'inhalateur à poudre sèche ou d'aérosol-doseur, de préférence aux fins d'administration par voie pulmonaire, nasale ou orale, et de préférence encore par inhalation, utile pour la prévention ou le traitement, notamment de troubles inflammatoires, allergiques et/ou respiratoires du type asthme et/ou maladie(s) pulmonaire(s) obstructive(s) chronique(s), ou tout autre trouble associé.
  • Synthesis of analogues of cryptopleurine
    作者:S. Foldeak
    DOI:10.1016/s0040-4020(01)97758-0
    日期:1971.1
    New analogues of cryptopleurine with different aromatic methoxyl and chloro substituents have been synthesized. Intermediate isomeric 1-hydroxyphenanthro[9.10b]quinolizidines have been isolated and characterized. Yields in the Pschorr reaction have been improved by the novel use of sulphite ion. Some of the compounds have been found to have antifungal activity.
    已经合成了具有不同的芳族甲氧基和氯取代基的隐叶嘌呤的新类似物。中间异构体1-羟基菲[9.10 b ]喹啉z已被分离和表征。通过新使用亚硫酸根离子可以提高Pschorr反应的收率。已经发现一些化合物具有抗真菌活性。
查看更多